Azacitidine in Patients with Acute Myeloid Leukemia: Impact of Intermediate-Risk Vs High-Risk Cytogenetics on Patient Outcomes

被引：0

作者：

Pleyer, Lisa ^{[1
,2
]}

Burgstaller, Sonja ^{[3
]}

Stauder, Reinhard ^{[4
]}

Girschikofsky, Michael ^{[5
]}

Linkesch, Werner ^{[6
]}

Pfeilstoecker, Michael ^{[7
]}

Autzinger, Eva Maria ^{[8
]}

Tinchon, Christoph ^{[9
]}

Sliwa, Thamer ^{[7
]}

Lang, Alois ^{[10
]}

Sperr, Wolfgang R. ^{[11
]}

Geissler, Dietmar ^{[12
]}

Krippl, Peter ^{[13
]}

Voskova, Daniela ^{[14
]}

Rossmann, Dieter H. ^{[15
]}

Schlick, Konstantin ^{[16
]}

Thaler, Josef ^{[3
]}

Halter, Britta ^{[4
]}

Machherndl-Spandl, Sigrid ^{[5
]}

Theiler, Georg ^{[17
]}

Valent, Peter ^{[11
]}

Eckmuellner, Otto ^{[18
]}

Greil, Richard ^{[1
,19
]}

机构：

[1] Paracelsus Med Univ Salzburg, Salzburg, Austria

[2] Salzburg Canc Res Inst, Ctr Clin Canc & Immunol Trials, Salzburg, Austria

[3] Klinikum Wels Grieskirchen, Wels, Austria

[4] Med Univ Innsbruck, A-6020 Innsbruck, Austria

[5] Elisabethinen Hosp, Linz, Austria

[6] Med Univ Graz, Graz, Austria

[7] Hanusch Hosp, Vienna, Austria

[8] Wilhelminenspital Stadt Wien, Vienna, Austria

[9] LKH Leoben, Leoben, Austria

[10] LKH Rankweil, Rankweil, Austria

[11] Med Univ Vienna, Vienna, Austria

[12] Klinikum Klagenfurt, Klagenfurt, Austria

[13] LKH Furstenfeld, Furstenfeld, Austria

[14] Gen Hosp Linz, Linz, Austria

[15] Hosp Steyr, Steyr, Austria

[16] PMU, Salzburg, Austria

[17] LKH Hartberg, Hartberg, Austria

[18] Forest Growth, Vienna, Austria

[19] Salzburg Canc Res Inst, Salzburg, Austria

来源：

BLOOD | 2014年 / 124卷 / 21期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：5

共 50 条

[41] Unrelated donor hematopoietic stem cell transplantation for pediatric de novo acute myeloid leukemia with intermediate- or high-risk cytogenetics
Park, Eu Gene
Yi, Eun Sang
Choi, Young Bae
Sung, Ki Woong
Koo, Hong Hoe
Yoo, Keon Hee
PEDIATRIC TRANSPLANTATION, 2019, 23 (04)
[42] Methylation Patterns in Patients with High-Risk Myelodysplatic Syndromes and Secondary Acute Myeloid Leukemia Treated with Azacitidine (high-risk MDS 2009 protocol from CETLAM Group)
Cabezon, Marta
Medvedeva, Yulia
Bargay, Joan
Xicoy, Blanca
Marce, Silvia
Guardia, Ramon
Brunet, Salut
Pedro, Carmen
Tormo, Mar
Marco, Victor
Escoda, Lourdes
Font, Llorenc
Ramila, Elena
Valcarcel, David
Maria Marti, Josep
Borras, Josep
Feliu, Evarist
Milla, Fuensanta
Vavouri, Tanya
Zamora, Lurdes
BLOOD, 2015, 126 (23)
[43] How to manage high-risk acute myeloid leukemia
E H Estey
Leukemia, 2012, 26 : 861 - 869
[44] High-Risk Acute Myeloid Leukemia: A Pediatric Prospective
Cacace, Fabiana
Iula, Rossella
De Novellis, Danilo
Caprioli, Valeria
D'Amico, Maria Rosaria
De Simone, Giuseppina
Cuccurullo, Rosanna
Wierda, William G.
Mahadeo, Kris Michael
Menna, Giuseppe
Tambaro, Francesco Paolo
BIOMEDICINES, 2022, 10 (06)
[45] How to manage high-risk acute myeloid leukemia
Estey, E. H.
LEUKEMIA, 2012, 26 (05) : 861 - 869
[46] Targeted therapies for high-risk acute myeloid leukemia
Perentesis, JP
Sievers, EL
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2001, 15 (04) : 677 - +
[47] Low Platelet Counts at Diagnosis Predict Better Survival for Patients with Intermediate-Risk Acute Myeloid Leukemia
Zhang, Yimin
Gu, Haihui
Chen, Qi
Zhang, Ying
Cheng, Hui
Yang, Jianmin
Wang, Jianmin
Hu, Xiaoxia
ACTA HAEMATOLOGICA, 2020, 143 (01) : 9 - 18
[48] NEDD9, an independent good prognostic factor in intermediate-risk acute myeloid leukemia patients
Pallares, Victor
Hoyos, Montserrat
Carmen Chillon, M.
Barragan, Eva
Prieto Conde, M. Isabel
Llop, Marta
Virtudes Cespedes, Maria
Nomdedeu, Josep F.
Brunet, Salut
Angel Sanz, Miguel
Gonzalez-Diaz, Marcos
Sierra, Jorge
Casanova, Isolda
Mangues, Ramon
ONCOTARGET, 2017, 8 (44) : 76003 - 76014
[49] PHARMACOECONOMIC EVALUATION OF ACUTE MYELOID LEUKEMIA AND MDS SYNDROMES (INTERMEDIATE AND HIGH RISK) TREATMENT WITH AZACITIDINE IN THE RUSSIAN FEDERATION
Kulikov, A.
Yagudina, R.
Misikova, B.
VALUE IN HEALTH, 2012, 15 (07) : A423 - A423
[50] The prognostic value of multilineage dysplasia in de novo acute myeloid leukemia patients with intermediate-risk cytogenetics is dependent on NPM1 mutational status
Diaz-Beya, Marina
Rozman, Maria
Pratcorona, Marta
Torrebadell, Montserrat
Camos, Mireia
Aguilar, Joseph L. I.
Esteve, Jordi
BLOOD, 2010, 116 (26) : 6147 - 6148

← 1 2 3 4 5 →